skip to content


Issue No. 23 | June 4, 2010

News and Features

Join AIDSinfo in Observing National Caribbean American HIV/AIDS Awareness Day

June 8 marks the fifth annual observance of National Caribbean American HIV/AIDS Awareness Day, a day that serves to increase awareness of HIV/AIDS in the Caribbean American community. Statistics from the Joint United Nations Programme on HIV/AIDS show that the Caribbean, including Puerto Rico and the U.S. Virgin Islands, has been more affected by HIV than any region outside sub-Saharan Africa.

AIDSinfo has developed a specialty page for this awareness day with information and resources concerning HIV and Caribbean Americans.

More information is available:

FDA Updates Selzentry (Maraviroc) Label to Include Changes for People with Renal Impairment

"On May 27, 2010, FDA approved changes to the labeling for Selzentry (maraviroc) 150 mg and 300 mg tablets to expand the patient population to include dosing recommendations for patients with renal impairment, add a contraindication for patients with severe renal impairment or end-stage renal disease, add a warning regarding postural hypotension for renal impaired patients, and add new Pharmacokinetics information related to renal impairment ... [.]”

The complete revised label will be available on the FDA Web site.

More information is available: